Trial · NCT04733157
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Postpartum Hemorrhage (PPH) | Up to day 2 postpartum | Calculated estimated blood loss exceeding 1000ml. Estimated Blood Loss (EBL) was calculated using laboratory values of hemoglobin levels before and after procedure. Postpartum hemorrhage is defined as blood loss exceeding 1000mL after cesarean section. |
| Secondary | Blood Loss Using Hemoglobin Values | Up to day 2 postpartum | Calculated blood loss using hemoglobin values. A mean value of blood loss calculated using hemoglobin values |
| Secondary | Mean Blood Loss as Estimated by Obstetrician | 2 hours | Visually estimated blood loss at time of caesarean section. Attending obstetrician gave an estimated value of blood loss after delivery. |
| Secondary | Occurrence of Postpartum Shock | Up to day 2 postpartum | Number of participants who had hypovolemic shock related to PPH as determined by assessing BP and pulse. |
| Secondary | Use of Supplementary Uterotonic(s) | Up to day 2 postpartum | Number of women requiring supplementary uterotonics |
| Secondary | Postpartum Transfusion | Up to day 2 postpartum | Number of women given postpartum transfusion |
| Secondary | Emergency Surgery for PPH | Up to day 2 postpartum | Number of participants who had emergency surgery for PPH including caesarean hysterectomies |
| Secondary | Change in Peripartum Haemoglobin | Up to day 2 postpartum | Mean change in haemoglobin concentration between the study group, calculated hemoglobin values at day 2 postpartum minus baseline hemoglobin values. |
| Secondary | Number of Participants With a Decrease in Peripartum Hemoglobin | Up to day 2 postpartum | Number of participants with a drop in hemoglobin more than 2g/dL or less than 2g/dL |
| Secondary | Change in Peripartum Haematocrit | Up to day 2 postpartum | Mean change in haematocrit percentage between the study groups from baseline to day 2 postpartum |
| Secondary | Admission Into Intensive Care Unit | Up to day 2 postpartum | Number of participants transferred to intensive care unit |
| Secondary | Death From Any Cause | Up to date of death or day 4 from admission | Number of participants who died from any cause |
| Secondary | Blood Pressure Measurements | Up to 2 hours after the caesarean section | Blood pressure at 15, 30, 45, 60, and 120 min after delivery |
| Secondary | Number of Mild Adverse Events | Up to 24 hours after administration | Number of mild events of nausea, vomiting, sensation of rings or spots of light in the visual field, dizziness |
| Secondary | Number of Severe Adverse Events | Up to day 3 postpartum | * Deep vein thrombosis (if the diagnosis is confirmed by Doppler ultrasound) * Pulmonary embolism (if the diagnosis is confirmed by radiological examination) * Myocardial infarction * Seizure * Renal failure requiring dialysis |
| Secondary | Any Other Unexpected Adverse Event | Up to day 3 postpartum | Number of unexpected events during and after the adminstration of study drug and duration of observation |
| Secondary | Length of Hospital Stay | Up to day 3 postpartum | Duration of hospital admission in days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04733157/registered